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 Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of hospital- and
community-associated infections. The formation of adherent clusters of cells known as
biofilms is an important virulence factor in MRSA pathogenesis. Previous studies showed
that subminimal inhibitory (sub-MIC) concentrations of methicillin induce biofilm for-
mation in the community-associated MRSA strain LAC. In this study we measured the abil-
ity sub-MIC concentrations of eight other β-lactam antibiotics and six non-β-lactam antibi-
otics to induce LAC biofilm. All eight β-lactam antibiotics, but none of the non-β-lactam
antibiotics, induced LAC biofilm. The dose-response effects of the eight β-lactam antibi-
otics on LAC biofilm varied from biphasic and bimodal to near-linear. We also found that
sub-MIC methicillin induced biofilm in 33 out of 39 additional MRSA clinical isolates,
which also exhibited biphasic, bimodal and linear dose-response curves. The amount of
biofilm formation induced by sub-MIC methicillin was inversely proportional to the sus-
ceptibility of each strain to methicillin. Our results demonstrate that induction of biofilm
by sub-MIC antibiotics is a common phenotype among MRSA clinical strains and is spe-
cific for β-lactam antibiotics. These findings may have relevance to the use of β-lactam
antibiotics in clinical and agricultural settings.
Keywords: antibiotic, bimodal, biofilm, biphasic, MRSA, Staphylococcus aureus, subminimal
inhibitory
INTRODUCTION
Staphylococcus aureus is a major human pathogen that represents a
growing public health burden in both hospital and community environ-
ments. The emergence of antibiotic-resistant clones such as methicillin-
resistant S. aureus (MRSA) has contributed to the spread of this bacterium
(Otto, 2012). In addition, S. aureus often forms matrix-encased biofilms on
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tissues and medical devices which confer additional antibiotic resistance
and further complicate treatment (Kiedrowski and Horswill, 2011).
Previous studies showed that subminimal inhibitory (sub-MIC) con-
centrations of methicillin and other β-lactam antibiotics can induce
biofilm formation in some MRSA strains (Kaplan et al., 2012). Antibiotic-
induced biofilm formation was evidently dependent on the release of
extracellular DNA (eDNA) since (i) the amount of eDNA in the biofilm
matrix increased upon exposure to low-level methicillin, (ii) a strain car-
rying a mutation in the atl gene, which encodes the major S. aureus
autolysin responsible for eDNA release, did not exhibit the biofilm induc-
tion phenotype, and (iii) the addition of exogenous DNase inhibited the
biofilm induction phenotype (Kaplan et al., 2012). Antibiotic-induced
biofilm formation may have clinical relevance because bacteria are
exposed to low concentrations of antibiotics during the course of routine
antibiotic chemotherapy (Craig, 1998; Odenholt, 2001). In addition, bac-
terial cells buried deep within a biofilm may be exposed to low levels of
antibiotics due to diffusion gradients (Singh et al., 2010). The routine use
of low-level antibiotics as growth promoters in agriculture may also
expose bacteria to low levels of the drugs (Smith et al., 2002; Marshall and
Levy, 2011).
The aim of the present study was to determine the specificity, preva-
lence and dose-response effects of low-level antibiotic-induced MRSA
biofilm formation. In this report we present evidence that induction of
biofilm by sub-MIC antibiotics is a common phenotype among MRSA
clinical strains and is specific for β-lactam antibiotics. Our findings may
shed light on the recalcitrance of some bacterial infections to antibiotic
treatment in clinical settings and the evolution of antibiotic-resistant bac-
teria in agricultural settings.
MATERIALS AND METHODS
Antibiotics
Daptomycin powder was obtained from Cubist Pharmaceuticals, Inc.
(Lexington, MA). All other antibiotics were purchased from Sigma-
Aldrich (St. Louis, MO). Antibiotic stock solutions were prepared at a
concentration of 10 mg/ml in sterile distilled water and then diluted in
fresh broth as described below. MIC testing was carried out using the
broth dilution method.
Bacterial strains
The 40 MRSA strains used in this study are listed in Table 1. A total of
27 strains were obtained from the Network on Antimicrobial Resistance
in Staphylococcus aureus (NARSA). These strains (designated ‘NRS’) were
isolated from patients in California, Connecticut, Georgia, Minnesota,
β-lactam-induced MRSA biofilm
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New York, Oregon and Tennessee, and are representative of 11 different
S. aureus PFGE (pulse field gel electrophoresis) types. An additional 12
strains (designated ‘GW’) were isolated from blood, wound and respira-
M. Ng and others
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TABLE 1. MRSA strains analyzed in this study. 
GW06 n.d. 21.0* 0.09 3.9
NRS751 USA100 20.8* 0.15 2.5
GW05 n.d. 19.4* 0.09 3.9
NRS702 USA300 18.8* 0.11 3.2
NRS716 USA300 18.3* 0.11 3.2
NRS715 USA600 18.1* 0.04 6.0
NRS745 USA1000 18.1* 0.09 3.5
NRS739 USA300 17.8* 0.11 4.2
NRS678 USA500 17.3* 0.07 4.3
NRS685 USA500 16.8* 0.12 3.0
NRS670 USA100 16.6* 0.12 2.5
NRS645 IBERIAN 16.5* 0.09 3.7
LAC USA300 16.2* 0.09 2.5
GW11 n.d. 16.2* 0.04 2.8
NRS123 USA400 15.6* 0.07 4.2
NRS648 USA600 15.5* 0.20 1.0
NRS686 IBERIAN 15.4* 0.07 3.9
GW07 n.d. 15.3* 0.15 1.4
NRS643 USA300 15.1* 0.10 3.5
NRS734 USA800 14.9* 0.15 2.1
NRS689 USA700 14.7* 0.09 6.0
NRS732 USA300 14.4* 0.07 2.8
GW10 n.d. 14.3* 0.12 3.5
NRS714 USA800 14.3* 0.07 3.7
GW02 n.d. 12.8* 0.10 6.0
NRS662 USA300 12.0* 0.11 4.0
GW03 n.d. 11.6* 0.04 6.0
NRS722 USA200 11.1* 0.11 3.3
GW12 n.d. 11.0* 0.11 5.6
NRS484 USA1100 8.2* 0.02 6.3
GW01 n.d. 6.4* 0.06 5.3
NRS717 USA100 5.3* 0.06 5.0
NRS483 USA1000 5.1* 0.07 4.6
NRS723 USA100 4.4* 0.09 5.7
NRS651 USA200 2.7 0.04 4.9
GW09 n.d. 2.5 0.02 6.0
GW08 n.d. 2.5 0.03 6.0
GW04 n.d. 1.7 0.01 6.0
NRS701 USA200 1.6 0.07 5.0
NRS100 USA300 1.1 0.01 4.9
a n.d., not determined.
b Maximum A620 nm value in the crystal violet binding assay. *, significantly different from no antibi-
otic control (P < 0.05).
c (A450 nm [no antibiotic]) - (A450 nm [0.7 μg/ml methicillin]).
Strain PFGE typea
Maximum biofilm
induction in sub-MIC
methicillin (A620 nm)
b
Sensitivity to 0.7
μg/ml methicillin
(ΔA450 nm)c
Methicillin
concentration at
maximum biofilm
induction (μg/ml)
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tory infections of patients at the George Washington University Hospital
in Washington, DC. To characterize these strains, colonies that exhibited
beta hemolysis on 5% sheep blood agar (BBL) were tested using a
BactiStaph® latex agglutination assay (Remel # R21143) to distinguish S.
aureus from coagulase negative staphylococci. Coagulase positive isolates
were then tested for antibiotic susceptibility using the Vitek 2 system (#
AST-GP67) that included cefoxitin which acts as a surrogate test for
oxacillin. Strains that exhibited a MIC for cefoxitin that was ≥8 μg/ml
were considered MRSA. No further genotyping was carried out on these
12 strains. S. aureus strain LAC, a well-characterized community-associat-
ed MRSA strain isolated from the Los Angeles County Jail (Miller et al.,
2005), was obtained from Kenneth Bayles of the University of Nebraska
Medical Center, Omaha, NE.
Bacterial growth and biofilm assays
Bacterial inocula were prepared in fresh broth from 18-h-old agar
colonies as previously described (Izano et al., 2008). Aliquots of inocula
(180 μl each, ca. 105 to 106 CFU/ml) were transferred to the wells of a 96-
well microtiter plate (catalog no. 353936; Falcon) containing 20 μl of
antibiotic solution at a concentration equal to ten times the desired final
concentration. The final concentrations tested in the biofilm assay
ranged from 0 × to 1 × MIC. Plates were incubated at 37°C for 18 to 24 h.
To quantitate bacterial growth, the absorbance of the broth was measured
in a microplate spectrophotometer set to 450 nm. The sensitivity of each
strain to sub-MIC methicillin (Table 1) was quantitated by measuring the
difference in the absorbance values (A450 nm) of broth cultures supple-
mented with 0 or 0.7 μg/ml methicillin (< 0.1 × MIC). For quantitation
of biofilm formation, wells were rinsed with water to remove loosely
adherent cells and then stained for 1 min with 200 μl of Gram’s crystal
violet. The wells were then rinsed with water and dried. The amount of
biofilm biomass was quantitated by destaining the wells with 200 μl of
33% acetic acid and then measuring the absorbance of the crystal violet
solution in a microplate spectrophotometer set at 620 nm. The maximum
biofilm induction value for each strain (Table 1) was equal to the highest
observed absorbance value (A620 nm) divided by the absorbance value at 0
μg/ml methicillin.
Statistics and reproducibility of results
All biofilm assays were carried out in duplicate or triplicate wells,
which exhibited an average variation in absorbance values of <10%. All
assays were repeated 2 to 5 times, and in all cases, the observed patterns
of growth inhibition and biofilm induction were reproducible. The sig-
nificance of differences between absorbance values was calculated using
β-lactam-induced MRSA biofilm
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a Student’s t-test. Correlation was measured using a Pearson correlation
coefficient.
RESULTS
The MRSA biofilm induction phenotype is specific for β-lactam antibiotics
Previous studies showed that biofilm formation by MRSA strain LAC
is strongly induced by sub-MIC methicillin (Kaplan et al., 2012). We test-
ed whether sub-MIC concentrations of eight other β-lactam antibiotics
also induced LAC biofilm. The β-lactam antibiotics we tested included six
of the penicillin class (penicillin, amoxicillin, ampicillin, pipericillin, naf-
cillin and cloxicillin) and two of the cephalosporin class (ceftriaxone and
cefazolin). Low-levels of all eight antibiotics significantly induced LAC
biofilm (Figure 1). The amount of biofilm induction ranged from a 9- to
21-fold increase over background biofilm in the absence of antibiotic.
The shapes of the dose-response curves for all eight antibiotics were
biphasic, with four antibiotics (amoxicillin, ampicillin, nafcillin and clox-
icillin) exhibiting a bimodal dose-response effect. Biofilm induction
occurred over a wide range of sub-MIC concentrations ranging from <0.2
× MIC for penicillin and ampicillin to >0.5 × MIC for nafcillin and cloxi-
cillin (Figure 1).
We also measured the ability of six non-β-lactam antibiotics to induce
biofilm formation in strain LAC. The antibiotics we tested included
trimethoprim/sulfamethoxazole, linezolid, vancomycin, daptomycin,
tigecycline, and rifampicin. Strain LAC exhibited little or no biofilm
M. Ng and others
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FIGURE 1. Bacterial growth and biofilm formation by S. aureus MRSA strain LAC in the presence of
sub-MIC concentrations of eight different β-lactam antibiotics. Bacterial growth (A490 nm) is indicated
along the left-hand y axes, biofilm formation (A620 nm) is indicated along the right-hand y axes, and
antibiotic concentration is indicated along the x axes. Values show mean absorbance values for dupli-
cate wells. Error bars were omitted for clarity. 
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induction when cultured in sub-MIC concentrations of these six antibi-
otics (Figure 2).
Prevalence of biofilm induction among MRSA clinical isolates
To determine the prevalence of the biofilm induction phenotype
among MRSA clinical strains, we measured the ability of sub-MIC methi-
cillin (0-6.3 μg/ml) to induce biofilm formation among 39 additional
MRSA clinical isolates (Table 1). The MIC of methicillin against most of
these strains was >8 μg/ml. A total of 33/39 strains (85%) exhibited sig-
nificant biofilm induction at one or more sub-MIC concentrations of
methicillin. Figure 3 shows examples of dose-response curves for four
inducible strains (GW02, GW03, GW06, GW07) and two non-inducible
strains (GW04, GW09). Inducible strains exhibited various patterns of
dose-dependent biofilm formation including biphasic (strain GW07),
bimodal (strain GW02) and near-linear (strain GW03). A total of four
strains (GW02, GW12, NRS734 and NRS751) exhibited a bimodal dose-
response effect.
MRSA biofilm induction correlates with methicillin susceptibility
MRSA strains that were more sensitive to methicillin (e.g., strain
GW07; Figure 3) appeared to exhibit biofilm induction at lower methi-
β-lactam-induced MRSA biofilm
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FIGURE 2. Bacterial growth and biofilm formation by S. aureus MRSA strain LAC in the presence of
sub-MIC concentrations of six different non-β-lactam antibiotics. Bacterial growth (A490 nm) is indi-
cated along the left-hand y axes, biofilm formation (A620 nm) is indicated along the right-hand y axes,
and antibiotic concentration is indicated along the x axes. Values show mean absorbance values for
duplicate wells. Error bars were omitted for clarity. 
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cillin concentrations than strains that were more resistant to methicillin
(e.g., strain GW03; Figure 3). To confirm this relationship, we graphed
the sensitivity of each strain to methicillin against the methicillin con-
centration at which maximum biofilm induction occurred (Figure 4A).
Methicillin sensitivity was quantitated by measuring the change in the
absorbance of the broth caused by 0.7 μg/ml methicillin (< 0.1 × MIC).
A significant negative correlation was observed (R2 = 0.517; P < 0.01).
Similarly, a significant positive correlation was observed when methicillin
sensitivity was graphed against the maximum amount of biofilm induc-
tion (R2 = 0.347; P < 0.05; Figure 4B).
DISCUSSION
Several previous studies demonstrated that sub-MIC levels of β-lactam
antibiotics can induce S. aureus biofilm formation (Haddadin et al., 2010;
Mirani and Jamil, 2011; Subrt et al., 2011; Kaplan et al., 2012). One study
M. Ng and others
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FIGURE 3. Bacterial growth and biofilm formation six clinical MRSA strains in the presence of sub-
MIC concentrations of sub-MIC methicillin. Bacterial growth (A490 nm) is indicated along the left-hand
y axes, biofilm formation (A620 nm) is indicated along the right-hand y axes, and antibiotic concentra-
tion is indicated along the x axes. Values show mean absorbance values for duplicate wells and error
bars indicate range. 
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demonstrated that S. aureus MRSA strains exhibit higher levels of biofilm
induction than methicillin-sensitive S. aureus (MSSA) strains, which usu-
ally exhibit high levels of biofilm formation in the absence of antibiotics
(Kaplan et al., 2012). In the present study we found that sub-MIC con-
centrations of β-lactam antibiotics, but not of non-β-lactam antibiotics,
induced biofilm formation in the MRSA strain LAC. Strain LAC is a mem-
ber of the USA300 clonal lineage that is commonly associated with com-
munity-acquired skin and soft tissue infections (Otto, 2010). The speci-
ficity of the biofilm induction phenotype for β-lactam antibiotics suggests
that β-lactam antibiotics have the potential to act as signal molecules
independent of their antimicrobial activity. Consistent with this hypothe-
sis, vancomycin, which also inhibits bacterial cell wall biosynthesis, did
not induce LAC biofilm when present at sub-MIC concentrations (Figure
2). Interestingly, previous studies have shown that resistance to β-lactam
antibiotics predates the modern antibiotic era (Davies, 2006; Bernier and
Surette, 2013; Sengupta et al., 2013), which also suggests that antibiotics
and antibiotic resistance determinants have other roles in nature.
The amount of biofilm induction exhibited by strain LAC in response
to sub-MIC concentrations of eight different β-lactam antibiotics (Figure
1) was 9- to 21-fold, consistent with the amount of biofilm induction
exhibited by strain LAC in response to sub-MIC methicillin, and by strain
FPR3757, another USA300 strain, in response to sub-MIC methicillin and
ampicillin (Kaplan et al., 2012). All of the β-lactam antibiotics tested in
the present study exhibited a biphasic dose-response curve, with low con-
centrations inducing biofilm and higher concentrations inhibiting
biofilm. Some β-lactam antibiotics (amoxicillin, ampicillin, nafcillin and
cloxicillin) exhibited a bimodal dose-response effect on LAC biofilm
(Figure 1), consistent with the bimodal dose-response effects of methi-
cillin on other MRSA strains (Kaplan et al., 2012). Previous studies
showed that the bimodal dose-response curve might be a superposition of
β-lactam-induced MRSA biofilm
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FIGURE 4. Relationship between methicillin sensitivity and biofilm induction among 39 MRSA clin-
ical strains. (A) Relationship between methicillin sensitivity (x axis) and the methicillin concentra-
tion that induced maximum biofilm induction (y axis). (B) Relationship between methicillin sensi-
tivity (x axis) and the maximum amount of biofilm induced by sub-MIC methicillin (y axis). 
8
Dose-Response: An International Journal, Vol. 12 [2014], Iss. 1, Art. 10
https://scholarworks.umass.edu/dose_response/vol12/iss1/10
two biphasic dose-effect curves because DNase I was able to inhibit the
first peak of biofilm formation but not the second peak in several MRSA
and MSSA strains (Kaplan et al., 2012). Since biofilm induction usually
occurs over a narrow range of antibiotic concentrations, more doses will
need to be tested in order to determine whether the bimodal biofilm
induction response in common for all β-lactam antibiotics.
β-lactam antibiotics are among the most common antibiotics used for
the treatment of severe infections (Talbot, 2013). As a general rule, most
patients who receive empiric antibiotics for sepsis prior to identification
of the offending organism receive a β-lactam antibiotic such as
piperacillin/tazobactam to kill Gram-negative bacteria, and vancomycin
to kill MRSA. It is possible that concomitant β-lactam antibiotics induce
MRSA biofilm formation and reduce the effectiveness of vancomycin in
some patients.
Transmission of MRSA from livestock to humans has recently been
confirmed using whole genome sequencing combined with single
nucleotide polymorphism analysis (Harrison et al., 2013). These findings
highlight the role of farm animals as a reservoir for MRSA. It is tempting
to speculate that administering low-level penicillin to farm animals may
facilitate the emergence of multidrug-resistant bacteria by means of
eDNA release and biofilm formation.
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